OSAKA -- Japanese pharma Shionogi hopes two joint ventures with China's Ping An Insurance Group -- one already set up in Hong Kong and the other pending in Shanghai -- will be able to leverage its partner's huge health care database to design new drugs and services.
Shionogi and Ping An signed a capital and operational tie-up in March. The two joint ventures will aim to develop new drugs based on a database of over 300 million people maintained by Ping An.
